Company: Edwards Lifesciences Corp

Form Type: 8-K

Filing Date: 2024-06-03

Corporate Action: Spin-off

Type: New

Accession Number: 000119312524152323

Comments: Edwards Lifesciences Corporation announced that it is no longer pursuing the previously planned spin-off of its Critical Care product group. Instead, the company has entered into a Stock and Asset Purchase Agreement with Becton, Dickinson and Company, which will acquire the business for $4.2 billion in cash.

Document Link: View Document